TrialNeurological research and practice2019

Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).

Kathrin Reetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.